Accelerating Global Clinical Development Through Smarter Regulatory Strategy
11:00 am - Tuesday 9th February 2027
- Navigating FDA, EMA, and NMPA expectations early to align development plans and enable smoother clinical progression
- Leveraging IND, CTA and IIT pathways to optimise streamline approvals, and reduce patient enrolment timelines
- Learning from successful global development programmes to identify regulatory strategies that have accelerated approvals, site activation, and clinical execution across major markets
